Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Psychoneuroendocrinology
|
January 1, 1993
Effect of chronic bromocriptine treatment on psychological profile of patients with PRL-secreting pituitary adenomas
A Rocco, F Mori, R Baldelli, et al.
Journal of Endocrinological Investigation
|
October 12, 2010
Gene variants associated to malignant thyroid disease in familial adenomatous polyposis: a novel APC germline mutation
A Martayan, L Sanchez-Mete, R Baldelli, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
April 20, 2002
Physiology and possible pathology of growth hormone secretagogues
A Peñalva, R Baldelli, J P Camiña, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 2, 2006
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma
S Grottoli, V Gasco, F Broglio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 14, 2000
Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy
A Colao, R Baldelli, P Marzullo, et al.
Clinical Endocrinology
|
February 21, 2006
Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children
R Baldelli, S Bellone, N Castellino, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 18, 1999
Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients
R Baldelli, E Ferretti, M L Jaffrain-Rea, et al.
Clinical Endocrinology
|
January 31, 2009
Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach
F Cadario, F Prodam, S Bellone, et al.
Diabetes Research and Clinical Practice
|
April 24, 2018
Everolimus is a new anti-cancer molecule: Metabolic side effects as lipid disorders and hyperglycemia
L Morviducci, F Rota, L Rizza, et al.
Parassitologia
|
August 13, 2004
[Monitoring of canine leishmaniasis in northern Italy: an update from a scientific network]
G Capelli, R Baldelli, E Ferroglio, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Psychoneuroendocrinology
|
January 1, 1993
Effect of chronic bromocriptine treatment on psychological profile of patients with PRL-secreting pituitary adenomas
A Rocco, F Mori, R Baldelli, et al.
Journal of Endocrinological Investigation
|
October 12, 2010
Gene variants associated to malignant thyroid disease in familial adenomatous polyposis: a novel APC germline mutation
A Martayan, L Sanchez-Mete, R Baldelli, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
April 20, 2002
Physiology and possible pathology of growth hormone secretagogues
A Peñalva, R Baldelli, J P Camiña, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 2, 2006
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma
S Grottoli, V Gasco, F Broglio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 14, 2000
Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy
A Colao, R Baldelli, P Marzullo, et al.
Clinical Endocrinology
|
February 21, 2006
Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children
R Baldelli, S Bellone, N Castellino, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 18, 1999
Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients
R Baldelli, E Ferretti, M L Jaffrain-Rea, et al.
Clinical Endocrinology
|
January 31, 2009
Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach
F Cadario, F Prodam, S Bellone, et al.
Diabetes Research and Clinical Practice
|
April 24, 2018
Everolimus is a new anti-cancer molecule: Metabolic side effects as lipid disorders and hyperglycemia
L Morviducci, F Rota, L Rizza, et al.
Parassitologia
|
August 13, 2004
[Monitoring of canine leishmaniasis in northern Italy: an update from a scientific network]
G Capelli, R Baldelli, E Ferroglio, et al.
Page
of 8